Lower CoQ10 impairs mitochondrial ATP production in skeletal muscle, which can manifest as fatigue, myalgias and weakness, particularly in patients taking statins that further reduce endogenous CoQ10 levels. This medication is commonly used for Hypertension.
Randomized trials and meta-analyses in statin-treated patients have shown that CoQ10 depletion and/or low circulating levels are associated with muscle symptoms, while supplementation has produced mixed but suggestive improvements in statin-associated myalgia and muscle pain severity.
Caso G et al. Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins. Am J Cardiol. 2007;99(10):1409-1412.; Qu H et al. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7(19):e009835.; Parker BA et al. A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy. Atherosclerosis. 2013;231(1):282-287.
Some side effects may be linked to nutrient depletion caused by this medication.
Coenzyme Q10 (CoQ10) plays a vital role in cellular energy production. However, our ability to produce CoQ10 naturally declines with age, and dietary sources rarely provide therapeutic levels. Additionally, beta-blocker medications can further deplete CoQ10 stores. Therefore, individuals taking beta-blockers may benefit from CoQ10 supplementation.